The nucleolin antagonist N6L and paclitaxel combination treatment could be a new promising therapeutic strategy for pancreatic ductal adenocarcinoma therapy.

Pancreatic cancer (PCa) is one of the most devastating cancers with few clinical signs and no truly effective therapy. In recent years, our team has demonstrated that nucleolin antagonists such as N6L could be a therapeutic alternative for this disease. In order to study a possible clinic development of N6L (multivalent pseudopeptide), we undertook to study the effect of combination of N6L with chemotherapies classically used for PCa on the survival of pancreatic cancer cells.

The future of lactoferrin: A closer look at LipoDuo technology.

Background: Lactoferrin (Lf), a multifunctional glycoprotein known for its roles in immune modulation, iron metabolism, and antimicrobial activity, has limited therapeutic efficacy due to poor bioavailability. Liposomal encapsulation of lactoferrin (LLf) offers a potential solution by improving its stability, absorption, and sustained release, making it a promising candidate for various clinical applications. This study aims to compare the effectiveness of LLf and plain Lf in cellular uptake, proliferation, and wound healing using HEK-293T and Caco-2 cell lines.

Hard-to-reach communities in the rural Ecuador: A qualitative perspective on dietary habits and physical activity.

While many studies focus on urban areas, it's vital to understand health-related behaviours in rural communities. This paper aims to explore the factors that influence dietary habits and physical activity from the perspective of men and women of different ethnic groups living in a hard-to-reach rural area in Ecuador. We conducted 5 focus groups with 37 participants (26 women) from diverse cultural and ethnic backgrounds in marginalized communities in Esmeraldas.